Cell cycle control as a promising target in melanoma
{{output}}
Purpose of review: This review highlights recent clinical developments in the therapeutic targeting of cell cycle control in melanoma with cyclin-dependent kinase inhibitors, checkpoint kinases, MDM2, MDM4 and p53 inhibitors. ... ...
